# FDA Inspection 1112911 - Biomat USA, Inc. - November 01, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/f7e094b8-bb73-412c-a93e-8db1721bec81/
Source feed: FDA_Inspections

> FDA Inspection 1112911 for Biomat USA, Inc. on November 01, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1112911
- Company Name: Biomat USA, Inc.
- Inspection Date: 2019-11-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1052032 - 2018-03-23](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/8dd09282-ab06-48e5-bcd7-abca4f2c40e3/)
- [FDA Inspection 939355 - 2015-08-14](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/abe843c4-d69f-4e67-a30d-b463d6d49012/)
- [FDA Inspection 606887 - 2009-08-18](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/f9cd40c3-8955-49b7-9238-eb7e69f135b4/)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/eca6b709-8c08-4f6c-b2c8-d56543715fd6

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d